Clinical Trials Logo
  1. Home
  2. Impaired Renal Function
  3. NCT01760031

Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy — RenProLong  

Impaired Renal Function Clinical Trial

Official title:
Remote Preconditioning for Contrast-Induced Acute Kidney Injury: Long-Term Follow up (RenPro Longterm)

Clinical Trial Summary

Remote ischemic preconditioning reduces the incidence of contrast-induced acute kidney injury in patients undergoing elective coronary angiography. This study was designed to acquire long-term data of initially randomized patients in the RenPro Trial.

Clinical Trial Description

Data of the RenPro Trial has been already published. In the present study data of longterm follow up are collected. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01760031
Study type Observational
Source University of Cologne
Contact
Status Active, not recruiting
Phase N/A
Start date July 2012
Completion date January 2013
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04252430 - RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects Phase 1
Completed NCT01716455 - Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function Phase 1
Completed NCT02431481 - Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011 Phase 1
Completed NCT02087566 - Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6) N/A
Completed NCT04179630 - Study of Aldafermin (NGM282) in Participants With Impaired Renal Function Phase 1
Completed NCT00779922 - Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function Phase 2
Completed NCT00784381 - Computer Prescribing System and Impaired Renal Function Phase 3
Completed NCT01507350 - Effects of Obesity Surgery on Renal Function
Completed NCT03776539 - A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 Phase 1
Completed NCT01035320 - Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment Phase 4
Completed NCT00604357 - CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment Phase 3
Completed NCT02965040 - A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function Phase 1
Completed NCT00981045 - Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function Phase 3
Completed NCT02467478 - Linagliptin's Effect on CD34+ Stem Cells Phase 4
Recruiting NCT04620590 - An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function Phase 4